drugset / Trial / NCT01928485
Green Tea Extract in Treating Patients With Low-Risk Prostate Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This randomized phase II trial studies how well green tea extract works in treating patients with low-risk prostate cancer. Green tea extract contains ingredients that may prevent or slow the growth of certain cancers.
Timeline
- Start
- 2013-08-30
- Primary completion
- 2016-10-05
- Completion
- 2016-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | green tea extract | Unknown | — | Oral |